TP53 and bladder transitional cell carcinoma: In adrenocortical carcinoma (ACC), bladder urothelial carcinoma (BLCA), BRCA, lung adenocarcinoma (LUAD), and lung squamous cell carcinoma (LUSC), NEAT1 expression was significantly decreased in p53-mutated tumors compared with p53 wild-type tumors.